Vukovic Vojo 4
4 · DELCATH SYSTEMS, INC. · Filed Feb 18, 2026
Research Summary
AI-generated summary of this filing
Delcath (DCTH) CMO Vojo Vukovic Receives Equity Awards
What Happened Vojo Vukovic, Chief Medical Officer of Delcath Systems, Inc. (DCTH), received two equity awards on February 17, 2026: a grant of options covering 56,500 shares and a restricted stock unit (RSU) award for 28,250 shares. Both awards are reported at $0 consideration (typical for stock-based compensation grants) and therefore show no cash paid or received.
Key Details
- Transaction date: February 17, 2026; Form 4 filed February 18, 2026.
- Awards: 56,500-share option grant (derivative) and 28,250 RSUs (derivative); both reported at $0.00 per share.
- Vesting for the option (F1): vests 1/36th per month beginning Feb 17, 2026 (monthly over 36 months), subject to continued employment and plan terms.
- Vesting for the RSUs (F2/F3): 1/3 vests on Feb 17, 2027; the remaining 2/3 vest in equal annual installments over the next two years (i.e., annual vesting on subsequent anniversaries), subject to continued service.
- Awards governed by the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan (as amended).
- Amount owned following the transaction is not specified in the provided excerpt.
Context These entries are equity compensation grants (coded "A" for award/grant) rather than open-market purchases or sales, so they reflect company compensation decisions, not immediate insider buying or selling. The option vests monthly over three years; the RSUs convert to common shares only as they vest and subject to continued employment. Because the reported price is $0, there was no cash outlay reported on the Form 4 for these awards.
Insider Transaction Report
- Award
Stock Option (Right to Buy)
[F1]2026-02-17+56,500→ 56,500 totalExercise: $9.40Exp: 2036-02-17→ Common Stock (56,500 underlying) - Award
Restricted Stock Units
[F2][F3]2026-02-17+28,250→ 28,250 total→ Common Stock (28,250 underlying)
Footnotes (3)
- [F1]The option will vest and become exercisable at the rate of one-thirty-sixth (1/36th) per month with the first such vesting to occur on February 17, 2026 and monthly thereafter for so long as the reporting person remains an employee of Delcath Systems, Inc. (and subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan, as amended).
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.
- [F3]Represents an RSU award, one-third of which shall vest on February 17, 2027 with the remaining 2/3 two-thirds of the RSUs vesting in equal annual installments over the following two years. The vesting of the RSUs is subject to the Reporting Person's continuous service through each such vesting date.